Focetria (influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted))
- Region
- 🇪🇺 EU
- Active substance
- influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted)
- Company
- Novartis Vaccines and Diagnostics S.r.l.
- Status
- Expired
- Therapeutic area
- Influenza, Human; Immunization; Disease Outbreaks
- EU approval
- Wed 02 May 2007
- Application
- EMEA/H/C/000710
- ATC
- J07BB02
- Official record
- www.ema.europa.eu
Indication
Prophylaxis of influenza caused by A (H1N1v) 2009 virus. Focetria should be used in accordance with official guidance.
Regulatory milestones
No milestones recorded in the last year.
Follow Focetria
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.